Cargando…

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma

BACKGROUND: OCT4 and BIRC5 are preferentially expressed in human cancer cells and mediate cancer cell survival and tumor maintenance. However, the molecular mechanism that regulates OCT4 and BIRC5 expression is not well characterized. METHODS: By manipulating OCT4 and BIRC5 expression in hepatocellu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Lu, Li, Chunguang, Shen, Shuwen, Yan, Yan, Ji, Weidan, Wang, Jinghan, Qian, Haihua, Jiang, Xiaoqing, Li, Zhigang, Wu, Mengchao, Zhang, Ying, Su, Changqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583731/ https://www.ncbi.nlm.nih.gov/pubmed/23433354 http://dx.doi.org/10.1186/1471-2407-13-82

Ejemplares similares

OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
por: Li, Chunguang, et al.
Publicado: (2012)

Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model
por: Xu, Gaoya, et al.
Publicado: (2014)

Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway
por: Li, Chunguang, et al.
Publicado: (2017)

BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response
por: Xu, Haiting, et al.
Publicado: (2022)

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)

hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers
por: Ji, Weidan, et al.
Publicado: (2011)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
por: Xu, Rongzhong, et al.
Publicado: (2021)

CircMMP9 accelerates the progression of hepatocellular carcinoma through the miR-149/CCND2 axis
por: Li, Xiaolou, et al.
Publicado: (2022)

FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration
por: Li, Chun-Ming, et al.
Publicado: (2023)

CDC42EP3 promotes glioma progression via regulation of CCND1
por: Yang, Zhigang, et al.
Publicado: (2022)

Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-Analysis
por: Li, Chunguang, et al.
Publicado: (2012)

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
por: Yuan, Chao, et al.
Publicado: (2021)

TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5
por: Wu, Mengqiu, et al.
Publicado: (2023)

Bioinformatics analysis of BIRC5 in human cancers
por: Ye, Han-Bin, et al.
Publicado: (2022)

Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally
por: Gil-Kulik, Paulina, et al.
Publicado: (2020)

Identification of microRNA-124 in regulation of Hepatocellular carcinoma through BIRC3 and the NF-κB pathway
por: Cao, Jia, et al.
Publicado: (2018)

Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models
por: Hu, Huanzhang, et al.
Publicado: (2014)

Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells
por: Thorne, Andrew, et al.
Publicado: (2023)

AURKB promotes gastric cancer progression via activation of CCND1 expression
por: Nie, Min, et al.
Publicado: (2020)

Downregulation of BIRC2 hinders the progression of rheumatoid arthritis through regulating TRADD
por: Rao, Yanting, et al.
Publicado: (2023)

Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential
por: Yamato, Azusa, et al.
Publicado: (2015)

MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer
por: Li, Wen-Cui, et al.
Publicado: (2019)

CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis
por: Ji, Qian-Kun, et al.
Publicado: (2019)

MiR‐378a‐3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation
por: Qian, Fuliang, et al.
Publicado: (2021)

Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis
por: Cao, Yajuan, et al.
Publicado: (2019)

MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR‐203 and promoting the expression of BIRC5
por: Zhang, Haimin, et al.
Publicado: (2019)

Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma
por: Gressot, Loyola V., et al.
Publicado: (2016)

BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma
por: Wang, Nan, et al.
Publicado: (2022)

Role of OCT1 in hepatocellular carcinoma
por: Li, Jingguo, et al.
Publicado: (2019)

CircANKRD52 Promotes the Tumorigenesis of Hepatocellular Carcinoma by Sponging miR-497-5p and Upregulating BIRC5 Expression
por: Zhang, Mingzhi, et al.
Publicado: (2021)

Gene Network Revealed Involvements of Birc2, Birc3 and Tnfrsf1a in Anti-Apoptosis of Injured Peripheral Nerves
por: Wang, Yongjun, et al.
Publicado: (2012)

Upregulation of LINC01503 promotes cervical cancer progression by targeting the miR-615-3p/CCND1 axis
por: Feng, Jing, et al.
Publicado: (2021)

Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer
por: Hu, Tingting, et al.
Publicado: (2015)

LncBIRC3-OT promotes the malignant progression of glioma by interacting with RELA to upregulate stanniocalcin-1 expression
por: Wang, Renjie, et al.
Publicado: (2023)

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1
por: Li, Xiahui, et al.
Publicado: (2021)

Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer
por: Li, Chunguang, et al.
Publicado: (2023)

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
por: Wang, Lu, et al.
Publicado: (2016)

BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression
por: Peng, Wei-zhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_25voh3nnp0g657pe6pf56dp56d